Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
In September 2009, SIGA Technologies received a $1.6 million research fund from the National Institutes of Health ("NIH") for its broad-spectrum antiviral candidates.
In August 2011, SIGA Technologies was awarded a $7.7 million grant from the National Institutes of Health (NIH) to develop an antiviral drug for treating and preventing Lassa fever and others of arenavirus origin.
In 2013, SIGA laid off its entire research and development division located in Corvallis, Oregon.
In May 2018, the FDA advisory committee decided that the benefits of SIGA's small molecule antiviral treatment, TPOXX, outweigh its potential risks.
In July 2019, SIGA signed a $23 million contract with the United States Department of Defense to create TPOXX's post-exposure prophylaxis.
In 2021, the company submitted an intravenous version of TPOXX to the FDA for approval.
Rate SIGA Technologies' efforts to communicate its history to employees.
Do you work at SIGA Technologies?
Is SIGA Technologies' vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Merck | 1891 | $64.2B | 74,000 | 2,290 |
| Esperion Therapeutics | 2008 | $332.3M | 218 | 28 |
| Salix Pharmaceuticals | 1989 | $1.1B | 1,000 | - |
| Neurocrine Biosciences | 1992 | $2.4B | 400 | 377 |
| Fortress Biotech | 2006 | $84.5M | 34 | - |
| bluebird bio | 1992 | $3.7M | 518 | 10 |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 692 |
| Amgen | 1980 | $33.4B | 22,000 | 666 |
| Human Genome Sciences | 1992 | $131.0M | 1,000 | - |
| Sutro Biopharma | 2003 | $62.0M | 160 | 8 |
Zippia gives an in-depth look into the details of SIGA Technologies, including salaries, political affiliations, employee data, and more, in order to inform job seekers about SIGA Technologies. The employee data is based on information from people who have self-reported their past or current employments at SIGA Technologies. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by SIGA Technologies. The data presented on this page does not represent the view of SIGA Technologies and its employees or that of Zippia.
SIGA Technologies may also be known as or be related to SIGA TECHNOLOGIES INC, SIGA Technologies, SIGA Technologies, Inc., Siga Technologies and Siga Technologies, Inc.